Caspofungin exposure-response relationships in adult patients with mucosal or invasive candidiasis.

Comisar, Wendy; Sun, Peng; Li, Susan; Sable, Carole; Schwartz, Michael; Bi, Sheng; Chow, Joseph; Ngai, Angela; Winchell, Gregory; Kartsonis, Nicholas; Stone, Julie

Comisar, Wendy; Sun, Peng; Li, Susan; Sable, Carole; Schwartz, Michael; Bi, Sheng; Chow, Joseph; Ngai, Angela; Winchell, Gregory; Kartsonis, Nicholas; Stone, Julie.

Afiliação

Comisar W; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Sun P; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Li S; GlaxoSmithKline, Collegeville, PA, USA.
Sable C; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Schwartz M; Johnson & Johnson, Wayne, PA, USA.
Bi S; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Chow J; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Ngai A; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Winchell G; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Kartsonis N; AstraZeneca LP, Wilmington, DE, USA.
Stone J; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.

Clin Pharmacol Drug Dev ; 3(1): 43-50, 2014 Jan.

Article em En | MEDLINE | ID: mdl-27128229

Palavras-chave

caspofungin; invasive candidiasis; mucosal candidiasis; pharmacodynamics; pharmacokinetics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article